| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REPH | Exit | RECRO PHARMA INC | $0 | – | -11,353 | -100.0% | -0.23% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -5,742 | -100.0% | -0.38% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -5,064 | -100.0% | -0.39% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -11,632 | -100.0% | -0.41% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -13,132 | -100.0% | -0.42% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -12,927 | -100.0% | -0.42% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INC | $0 | – | -2,428 | -100.0% | -0.44% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -4,082 | -100.0% | -0.47% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -3,926 | -100.0% | -0.47% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -1,123 | -100.0% | -0.47% | – |
| GRFS | Exit | GRIFOLS S Asp adr rep b nvt | $0 | – | -13,196 | -100.0% | -0.48% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -3,498 | -100.0% | -0.50% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -2,112 | -100.0% | -0.51% | – |
| CKPT | Exit | CHECKPOINT THERAPEUTICS INC | $0 | – | -112,760 | -100.0% | -0.51% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -3,127 | -100.0% | -0.51% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -1,518 | -100.0% | -0.53% | – |
| IQV | Exit | IQVIA HLDGS INC | $0 | – | -1,985 | -100.0% | -0.54% | – |
| TECH | Exit | BIO TECHNE CORP | $0 | – | -1,551 | -100.0% | -0.55% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -28,490 | -100.0% | -0.69% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -30,075 | -100.0% | -0.69% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -9,725 | -100.0% | -0.70% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -3,674 | -100.0% | -0.76% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -12,005 | -100.0% | -0.78% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -9,770 | -100.0% | -0.81% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -10,852 | -100.0% | -0.82% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -9,479 | -100.0% | -0.83% | – |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -20,844 | -100.0% | -0.86% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -17,339 | -100.0% | -0.88% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -6,780 | -100.0% | -0.90% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -33,641 | -100.0% | -0.92% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -50,378 | -100.0% | -0.94% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -13,214 | -100.0% | -0.98% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -5,625 | -100.0% | -1.01% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -14,215 | -100.0% | -1.01% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -6,190 | -100.0% | -1.08% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -18,631 | -100.0% | -1.14% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -9,700 | -100.0% | -1.18% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -2,439 | -100.0% | -1.22% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -8,534 | -100.0% | -1.39% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -10,659 | -100.0% | -1.43% | – |
| PRQR | Exit | PROQR THRAPEUTICS N V | $0 | – | -138,461 | -100.0% | -1.44% | – |
| FBIO | Exit | FORTRESS BIOTECH INC | $0 | – | -613,551 | -100.0% | -1.56% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -9,699 | -100.0% | -1.70% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -28,858 | -100.0% | -1.72% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -9,933 | -100.0% | -1.76% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -13,684 | -100.0% | -1.99% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -20,124 | -100.0% | -2.18% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -8,279 | -100.0% | -2.54% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -4,721 | -100.0% | -2.60% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -18,020 | -100.0% | -2.78% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -33,000 | -100.0% | -3.02% | – |
| MTD | Exit | METTLER TOLEDO INTERNATIONAL | $0 | – | -3,235 | -100.0% | -4.12% | – |
| LABU | Exit | DIREXION SHS ETF TRsp biotch bl new | $0 | – | -99,855 | -100.0% | -5.58% | – |
| IBB | Exit | ISHARES TRcall | $0 | – | -85,000 | -100.0% | -15.28% | – |
| IBB | Exit | ISHARES TRnasdaq biotech | $0 | – | -125,000 | -100.0% | -22.48% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| METTLER-TOLEDO INTL CMN | 20 | Q3 2019 | 4.7% |
| ALNYLAM PHARMACEUTICALS, INC. CMN | 20 | Q3 2019 | 5.0% |
| VERTEX PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.0% |
| ILLUMINA, INC. CMN | 20 | Q3 2019 | 4.4% |
| SEATTLE GENETICS, INC. CMN | 20 | Q3 2019 | 4.0% |
| ALEXION PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.3% |
| INCYTE CORPORATION CMN | 20 | Q3 2019 | 4.4% |
| NEKTAR THERAPEUTICS CMN | 20 | Q3 2019 | 4.9% |
| REGENERON PHARMACEUTICALS | 20 | Q3 2019 | 3.8% |
| CELGENE CORPORATION CMN | 20 | Q3 2019 | 3.8% |
View Opus Point Partners Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-17 |
| 13F-HR | 2017-11-14 |
View Opus Point Partners Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.